-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Hoth Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
- Hoth Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.65M, a 3.68% increase year-over-year.
- Hoth Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$7.49M, a 25.1% increase year-over-year.
- Hoth Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$7.69M, a 30.5% increase from 2022.
- Hoth Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$11.1M, a 21.5% increase from 2021.
- Hoth Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$14.1M, a 93.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)